Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Peripheral Arterial Disease: Features

Interview
Latest Updates on the SPORTS Trial and HEAL Registry
11/14/2024
At the 2024 Amputation Prevention Symposium, interventional angiologist Thomas Zeller, MD, discussed his presentations on the SPORTS Registry and the HEAL study.
At the 2024 Amputation Prevention Symposium, interventional angiologist Thomas Zeller, MD, discussed his presentations on the SPORTS Registry and the HEAL study.
At the 2024 Amputation...
11/14/2024
Vascular Disease Management
Jos van den Berg, MD, PhD
CLI Global Society
What's New With the European Chapter of the CLI Global Society
11/13/2024
In this discussion recorded at AMP 2024, CLI Global Society European Chapter Chairman Jos van den Berg, MD, and Vice-Chairman Thomas Zeller, MD, discuss the work that the Chapter has been doing to improve the lives of patients with critical...
In this discussion recorded at AMP 2024, CLI Global Society European Chapter Chairman Jos van den Berg, MD, and Vice-Chairman Thomas Zeller, MD, discuss the work that the Chapter has been doing to improve the lives of patients with critical...
In this discussion recorded at...
11/13/2024
Vascular Disease Management
Case Report
Occluded Tibiopedal Access to Cross and Treat Complex Tibial Artery Occlusive Disease in a Patient With Critical Limb Ischemia
11/08/2024
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been...
11/08/2024
Vascular Disease Management
Dr Eric Secemsky
Sponsored Video
The Purpose and Value of the ELEGANCE Registry
11/01/2024
Dr Eric Secemsky discusses the ELEGANCE Registry, which aims to collect real-world data on populations not previously represented in PAD trials.
Dr Eric Secemsky discusses the ELEGANCE Registry, which aims to collect real-world data on populations not previously represented in PAD trials.
Dr Eric Secemsky discusses the...
11/01/2024
Vascular Disease Management
Abigail Mize
CLI Global Society
Why You Should Join the Critical Limb Ischemia Global Society
11/01/2024
CLI Global Society Committee Members Abigail Mize and Dr. David B. Alper discusses the benefits of being a Society member.
CLI Global Society Committee Members Abigail Mize and Dr. David B. Alper discusses the benefits of being a Society member.
CLI Global Society Committee...
11/01/2024
Vascular Disease Management
Dr Katzen
CLI Global Society
Join the Critical Limb Ischemia Global Society!
11/01/2024
CLI Global Society President Barry Katzen, MD, discusses why you should join the Society.
CLI Global Society President Barry Katzen, MD, discusses why you should join the Society.
CLI Global Society President...
11/01/2024
Vascular Disease Management
Dr Fadi Saab
CLI Global Society
The CLI Global Society Publications Committee: Challenging the Status Quo
11/01/2024
Learn about the CLI Society Publications Committee and how their work is changing the way patients with CLI are treated.
Learn about the CLI Society Publications Committee and how their work is changing the way patients with CLI are treated.
Learn about the CLI Society...
11/01/2024
Vascular Disease Management
Case Report
Right Innominate Artery Endovascular Intervention and Concomitant Use of Carotid Embolic Protection Device via Single Radial Access
10/25/2024
Observations suggest that up to 8% of individuals initially diagnosed with suspected subclavian steal syndrome may present with innominate artery lesions.
Observations suggest that up to 8% of individuals initially diagnosed with suspected subclavian steal syndrome may present with innominate artery lesions.
Observations suggest that up to...
10/25/2024
Vascular Disease Management
Interview
Evaluating the Auryon Laser Atherectomy System in Diabetic Patients: A Subgroup Analysis
10/23/2024
John Rundback, MD, spoke with VDM about his AMP 2024 presentation on a subgroup analysis of the PATHFINDER Registry, which is a prospective, nonrandomized, multicenter study that evaluated the performance and outcome of the Auryon laser...
John Rundback, MD, spoke with VDM about his AMP 2024 presentation on a subgroup analysis of the PATHFINDER Registry, which is a prospective, nonrandomized, multicenter study that evaluated the performance and outcome of the Auryon laser...
John Rundback, MD, spoke with...
10/23/2024
Vascular Disease Management
Dr Edward Kim
Sponsored Interview
Upgrading Interventional Labs to Improve Workflow and Efficiency at Mount Sinai Health System
10/17/2024
Edward Kim, MD, from Mount Sinai Health System, recently shared his views on replacing his aging imaging equipment to improve the efficiency of the interventional radiology suite at Mount Sinai.
Edward Kim, MD, from Mount Sinai Health System, recently shared his views on replacing his aging imaging equipment to improve the efficiency of the interventional radiology suite at Mount Sinai.
Edward Kim, MD, from Mount Sinai...
10/17/2024
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement